Annual long term debt:
$1.25B-$9.71M(-0.77%)Summary
- As of today (June 22, 2025), ALNY annual long term debt is $1.25 billion, with the most recent change of -$9.71 million (-0.77%) on December 31, 2024.
- During the last 3 years, ALNY annual long term debt has risen by +$297.12 million (+31.05%).
- ALNY annual long term debt is now -1.89% below its all-time high of $1.28 billion, reached on December 31, 2022.
Performance
ALNY Long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly long term debt:
$1.26B+$1.47M(+0.12%)Summary
- As of today (June 22, 2025), ALNY quarterly long term debt is $1.26 billion, with the most recent change of +$1.47 million (+0.12%) on March 31, 2025.
- Over the past year, ALNY quarterly long term debt has dropped by -$3.93 million (-0.31%).
- ALNY quarterly long term debt is now -2.08% below its all-time high of $1.28 billion, reached on September 30, 2022.
Performance
ALNY Quarterly long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
ALNY Long term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.8% | -0.3% |
| 3 y3 years | +31.1% | +31.6% |
| 5 y5 years | +354.2% | +355.3% |
ALNY Long term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.9% | +31.1% | -2.1% | +32.2% |
| 5 y | 5-year | -1.9% | +354.2% | -2.1% | +355.3% |
| alltime | all time | -1.9% | >+9999.0% | -2.1% | >+9999.0% |
ALNY Long term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.26B(+0.1%) |
| Dec 2024 | $1.25B(-0.8%) | $1.25B(-0.4%) |
| Sep 2024 | - | $1.26B(-0.2%) |
| Jun 2024 | - | $1.26B(+0.2%) |
| Mar 2024 | - | $1.26B(-0.3%) |
| Dec 2023 | $1.26B(-1.1%) | $1.26B(-0.3%) |
| Sep 2023 | - | $1.27B(-0.4%) |
| Jun 2023 | - | $1.27B(-0.4%) |
| Mar 2023 | - | $1.28B(-0.1%) |
| Dec 2022 | $1.28B(+33.6%) | $1.28B(-0.3%) |
| Sep 2022 | - | $1.28B(+35.0%) |
| Jun 2022 | - | $949.74M(-0.5%) |
| Mar 2022 | - | $954.10M(-0.3%) |
| Dec 2021 | $957.04M(+97.6%) | $957.04M(+33.0%) |
| Sep 2021 | - | $719.83M(-0.3%) |
| Jun 2021 | - | $721.71M(+50.5%) |
| Mar 2021 | - | $479.61M(-1.0%) |
| Dec 2020 | $484.32M(+75.4%) | $484.32M(+62.9%) |
| Sep 2020 | - | $297.26M(+5.6%) |
| Jun 2020 | - | $281.62M(+2.1%) |
| Mar 2020 | - | $275.78M(-0.1%) |
| Dec 2019 | $276.13M(+820.4%) | $276.13M(-0.1%) |
| Sep 2019 | - | $276.46M(-10.0%) |
| Jun 2019 | - | $307.21M(-1.6%) |
| Mar 2019 | - | $312.30M(+941.0%) |
| Dec 2018 | $30.00M | $30.00M(0.0%) |
| Sep 2018 | - | $30.00M(0.0%) |
| Jun 2018 | - | $30.00M(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $30.00M(0.0%) |
| Dec 2017 | $30.00M(-80.0%) | $30.00M(-80.0%) |
| Sep 2017 | - | $150.00M(0.0%) |
| Jun 2017 | - | $150.00M(0.0%) |
| Mar 2017 | - | $150.00M(0.0%) |
| Dec 2016 | $150.00M(+4962.4%) | $150.00M(0.0%) |
| Sep 2016 | - | $150.00M(0.0%) |
| Jun 2016 | - | $150.00M(>+9900.0%) |
| Sep 2008 | - | $719.00K(-23.3%) |
| Jun 2008 | - | $938.00K(-52.0%) |
| Mar 2008 | - | $1.96M(-34.0%) |
| Dec 2007 | $2.96M(-49.9%) | $2.96M(-24.9%) |
| Sep 2007 | - | $3.95M(-19.6%) |
| Jun 2007 | - | $4.91M(-3.1%) |
| Mar 2007 | - | $5.07M(-14.4%) |
| Dec 2006 | $5.92M(+7.2%) | $5.92M(-8.0%) |
| Sep 2006 | - | $6.44M(+1.6%) |
| Jun 2006 | - | $6.33M(+19.1%) |
| Mar 2006 | - | $5.32M(-3.6%) |
| Dec 2005 | $5.52M(-13.9%) | $5.52M(-4.5%) |
| Sep 2005 | - | $5.78M(-6.5%) |
| Jun 2005 | - | $6.19M(-4.5%) |
| Mar 2005 | - | $6.48M(+1.0%) |
| Dec 2004 | $6.41M(+392.8%) | $6.41M(-2.7%) |
| Sep 2004 | - | $6.59M(+15.5%) |
| Jun 2004 | - | $5.71M(+203.6%) |
| Mar 2004 | - | $1.88M(+44.4%) |
| Dec 2003 | $1.30M | $1.30M |
FAQ
- What is Alnylam Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual long term debt year-on-year change?
- What is Alnylam Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly long term debt year-on-year change?
What is Alnylam Pharmaceuticals annual long term debt?
The current annual long term debt of ALNY is $1.25B
What is the all time high annual long term debt for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual long term debt is $1.28B
What is Alnylam Pharmaceuticals annual long term debt year-on-year change?
Over the past year, ALNY annual long term debt has changed by -$9.71M (-0.77%)
What is Alnylam Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of ALNY is $1.26B
What is the all time high quarterly long term debt for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly long term debt is $1.28B
What is Alnylam Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, ALNY quarterly long term debt has changed by -$3.93M (-0.31%)